Literature DB >> 3160668

Biological effects of gamma-interferon on human tumor cells: quantity and affinity of cell membrane receptors for gamma-IFN in relation to growth inhibition and induction of HLA-DR expression.

U Ucer, H Bartsch, P Scheurich, K Pfizenmaier.   

Abstract

A large difference in the number of gamma-IFN receptors was found on a variety of human tumor cell lines with a range of 0.4 to 15 X 10(3) binding sites/cell. The receptor number did not correlate with the potential responsiveness of the cells to gamma-IFN, in regard to either growth inhibition or induction of HLA-DR expression, two independently regulated gamma-IFN effects. However, with respect to HLA-DR expression it was found that the gamma-IFN sensitivity of inducible cell lines depended on the number of receptors, so that with increasing number of receptors present on these cells lower doses of gamma-IFN were required for induction of the gamma-IFN effect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3160668     DOI: 10.1002/ijc.2910360116

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

1.  Differential growth inhibition and enhancement of major histocompatibility complex class I antigen expression by interferons in a small-cell lung cancer cell line and its doxorubicin-selected multidrug-resistant variant.

Authors:  S P Cole; B M Campigotto; J G Johnson; B E Elliott
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Recombinant human interferon gamma exerts an anti-proliferative effect and modulates the expression of human leukocyte antigens A,B,C and DR in human urothelial cell lines.

Authors:  S S Ottesen; V Ahrenkiel; J Kieler
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

3.  Interferon receptors on the surface of interferon-sensitive and interferon-resistant urothelial carcinomas.

Authors:  J W Grups; F C Bange
Journal:  Urol Res       Date:  1990

Review 4.  Big Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy.

Authors:  Lisheng Ge; Neil T Hoa; Zechariah Wilson; Gabriel Arismendi-Morillo; Xiao-Tang Kong; Rajeev B Tajhya; Christine Beeton; Martin R Jadus
Journal:  Int Immunopharmacol       Date:  2014-07-12       Impact factor: 4.932

5.  Interferon gamma encapsulated into liposomes enhances the activity of monocytes and natural killer cells and has antiproliferative effects on tumor cells in vitro.

Authors:  I Rutenfranz; A Bauer; H Kirchner
Journal:  Blut       Date:  1990-07

6.  The expression of MHC antigens on cultured oral keratinocytes and relationship to malignancy.

Authors:  I J Crane; S Q Rice; J Luker; L de Gay; C Scully; S S Prime
Journal:  Br J Exp Pathol       Date:  1988-10

7.  Small cell lung cancer cells express the late stage gBK tumor antigen: a possible immunotarget for the terminal disease.

Authors:  Neil T Hoa; Lisheng Ge; Rajeev B Tajhya; Christine Beeton; Andrew N Cornforth; Amir Abolhoda; Nils Lambrecht; Maria DaCosta-Iyer; Yi Ouyang; Anthony P Mai; Erin Hong; Judy Shon; Michelle J Hickey; Kate L Erickson; Carol A Kruse; Martin R Jadus
Journal:  Am J Transl Res       Date:  2014-05-15       Impact factor: 4.060

8.  Interferon-gamma released by gluten-stimulated celiac disease-specific intestinal T cells enhances the transepithelial flux of gluten peptides.

Authors:  Michael T Bethune; Matthew Siegel; Samuel Howles-Banerji; Chaitan Khosla
Journal:  J Pharmacol Exp Ther       Date:  2009-02-13       Impact factor: 4.030

9.  Effects of interferon gamma on the proliferation and modulation of cell-surface structures of human ovarian carcinoma cell lines.

Authors:  V J Möbus; W Asphal; P G Knapstein; R Kreienberg
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

10.  Expression of interferon-gamma receptors on bladder cancer cells: does it correlate with biological response?

Authors:  S J Hawkyard; A M Jackson; R A Hawkins; K James; J F Smyth; G D Chisholm
Journal:  Urol Res       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.